- Home
- CTSO vs OPHC Comparison
CTSO vs OPHC Comparison
Compare CTSO & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- OPHC
- Stock Information
- Founded
- CTSO 1997
- OPHC 2000
- Country
- CTSO United States
- OPHC United States
- Employees
- CTSO N/A
- OPHC N/A
- Industry
- CTSO Medical/Dental Instruments
- OPHC Major Banks
- Sector
- CTSO Health Care
- OPHC Finance
- Exchange
- CTSO Nasdaq
- OPHC Nasdaq
- Market Cap
- CTSO 52.6M
- OPHC 51.8M
- IPO Year
- CTSO N/A
- OPHC N/A
- Fundamental
- Price
- CTSO $1.03
- OPHC $4.57
- Analyst Decision
- CTSO Buy
- OPHC
- Analyst Count
- CTSO 2
- OPHC 0
- Target Price
- CTSO $5.50
- OPHC N/A
- AVG Volume (30 Days)
- CTSO 134.9K
- OPHC 7.7K
- Earning Date
- CTSO 08-12-2025
- OPHC 08-05-2025
- Dividend Yield
- CTSO N/A
- OPHC N/A
- EPS Growth
- CTSO N/A
- OPHC 30.24
- EPS
- CTSO N/A
- OPHC 1.33
- Revenue
- CTSO $35,332,238.00
- OPHC $39,980,000.00
- Revenue This Year
- CTSO $18.34
- OPHC N/A
- Revenue Next Year
- CTSO $19.82
- OPHC N/A
- P/E Ratio
- CTSO N/A
- OPHC $3.40
- Revenue Growth
- CTSO 15.37
- OPHC 53.28
- 52 Week Low
- CTSO $0.71
- OPHC $3.53
- 52 Week High
- CTSO $1.61
- OPHC $5.90
- Technical
- Relative Strength Index (RSI)
- CTSO 49.00
- OPHC 57.75
- Support Level
- CTSO $0.93
- OPHC $4.42
- Resistance Level
- CTSO $1.39
- OPHC $4.62
- Average True Range (ATR)
- CTSO 0.13
- OPHC 0.07
- MACD
- CTSO -0.02
- OPHC 0.01
- Stochastic Oscillator
- CTSO 34.92
- OPHC 65.38
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.